Hyloris' Maxigesic IV receives FDA approval for pain management
Hyloris Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for new drug application (NDA) for Maxigesic IV to manage pain.
Page 3 - Van Rompay News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Van Rompay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Van Rompay Today - Breaking & Trending Today
Hyloris shareholders approve all resolutions at the Annual
56,22% of shares represented physically, virtually or by proxy voteAll documents related to the 2023 AGM are available on the Hyloris website Regulated...
Source: globenewswire.com
Hyloris shareholders approve all resolutions at the Annual General Meeting
56,22% of shares represented physically, virtually or by proxy voteAll documents related to the 2023 AGM are available on the Hyloris website Regulated Information – Inside Information -... | June 13, 2023
Source: marketscreener.com
Hyloris has been granted EUR 1 million in non-dilutive funding from the Walloon Region
Regulated Information - Liège, Belgium – 08 June 2023 – 6 PM CET – Hyloris Pharmaceuticals SA , a specialty biopharma company committed to addressing unmet medical... | June 8, 2023
Source: marketscreener.com
Hyloris announces submission of Maxigesic® IV packaging
Additional extractable & leachable data generated by an accredited lab facility located in North AmericaResults analyzed and evaluated by toxicological...
Source: globenewswire.com